According to a previous study, the hepatoprotective effect of glycyrrhizin in viral hepatitis patients is due to its cytoprotective effect via the suppression of TNF-α-induced cytotoxicity and inhibition of immune-mediated cytotoxicity against hepatocytes [35–37]. The gene discussed is TNF; the disease is viral hepatitis.